 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Recommend company
|
Yalelaan 46
3584 CM Utrecht
Netherlands
|
|
Portrait
PanGenetics is headquartered in Utrecht, The Netherlands with an office near Cambridge in the UK. The company specializes in taking antibodies at the late research stage through to clinical proof of concept. The company employs a lean business model with most development activities outsourced to specialist providers in Europe. The most advanced programs of PanGenetics are PG102, a CD40 antagonist that has already shown promise in an open label Crohn's study, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company's management, board and advisors comprise many of the world's leading antibody developers.
Industrial Sectors
Additional information
PanGenetics BV
Utrecht, Netherlands
News
|
|
|
|
|
|
Top
